References
- Bloch KC, Nadarajah R, Jacobs R. Chryseobacterium meningosepticum: an emerging pathogen among immunocompromized adults. Report of 6 cases and literature review. Medicine (Baltimore) 1997; 76: 30–41
- Kim KK, Kim MK, Lim JH, Park HY, Lee ST. Transfer of Chryseobacterium meningosepticum and Chryseobacterium miricola to Elizabethkingia gen. nov. as Elizabethkingia meningoseptica comb. nov. and Elizabethkingia miricola comb. nov. Int J Syst Evol Microbiol 2005; 55: 1287–93
- Chiu CH, Waddingdon M, Greenberg D, Schreckenberger PC, Carnahan AM. Atypical Chryseobacterium meningosepticum and meningitis and sepsis in newborns and the immunocompromized, Taiwan. Emerg Infect Dis 2000; 6: 481–6
- Lin PY, Chu C, Su LH, Huang CT, Chang WY, Chiu CH. Clinical and microbiological analysis of bloodstream infections caused by Chryseobacterium meningosepticum in non-neonatal patients. J Clin Microbiol 2004; 42: 3353–5
- Hung PP, Lin YH, Lin CF, Liu MF, Shi ZY. Chryseobacterium meningosepticum infection: antibiotic susceptibility and risk factors for mortality. J Microbiol Immunol Infect 2008; 41: 137–44
- Lu CH, Huang CR, Tsai NW, Chang CS, Chuang YC, Lee PY, et al. An adult case of Chryseobacterium meningosepticum meningitis. Jpn J Infect Dis 2004; 57: 214–5
- Lee CC, Chen PL, Wang LR, Lee HC, Chang CM, Lee NY, et al. Fatal case of community acquired bacteremia and necrotizing fasciitis caused by Chryseobacterium meningosepticum: case report and review of the literature. J Clin Microbiol 2006; 44: 1181–3
- Lee CH, Lin WC, Chia JH, Su LH, Chien CC, Mao AH, et al. Community acquired osteomyelitis caused by Chryseobacterium meningosepticum: case report and literature review. Diagn Microbiol Infect Dis 2008; 60: 89–93
- Wu VC, Tsai TJ, Wang R, Hsueh PR. Peritonitis caused by Chryseobacterium meningosepticum in a patient undergoing continuous ambulatory peritoneal dialysis. J Formos Med Assoc 2003; 102: 270–2
- Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128–40
- Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 17th informational supplement. CLSI document M100-S17. Wayne, PA: Clinical and Laboratory Standards Institute; 2007.
- Horan TC, Emori TG. Definitions of key terms used in the NNIS System. Am J Infect Control 1997; 25: 112–6
- Wu CJ, Lee HC, Lee NY, Shih HI, Ko NY, Wang LR, et al. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996–2003. J Microbiol Immunol Infect 2006; 39: 135–43
- Ceyhan M, Yildirim I, Tekeli A, Yurdakok M, Us E, Altun B, et al. A Chryseobacterium meningosepticum outbreak observed in 3 clusters involving both neonatal and non-neonatal pediatric patients. Am J Infection Control 2008; 36: 453–7
- Fraser SL, Jorgensen JH. Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing. Antimicrob Agents Chemother 1997; 41: 2738–41
- Hsueh PR, Teng LJ, Yang PC, Ho SW, Luh KT. Susceptibilities of Chryseobacterium indologenes and Chryseobacterium meningosepticum to cefepime and cefpirome. J Clin Microbiol 1997; 35: 3323–4
- Kirby JT, Sader HS, Walsh TR, Jones RN. Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997–2001). J Clinl Microbiol 2004; 42: 445–8
- Lin YT, Chan YJ, Chiu CH, Lin ML, Yu KW, Wang FD, et al. Tigecycline and colistin susceptibility of Chryseobacterium meningosepticum isolated from blood in Taiwan. Int J Antimicrob Agents 2009; 34: 100–1